1,081
Views
55
CrossRef citations to date
0
Altmetric
Research Paper

Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer

, , , , , , , , , , , , & show all
Pages 574-585 | Received 09 Dec 2010, Accepted 22 Jun 2011, Published online: 01 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ping Lu, Shai White-Gilbertson, Rose Nganga, Mark Kester & Christina Voelkel-Johnson. (2019) Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide. Cancer Biology & Therapy 20:6, pages 922-930.
Read now
Ying-Yu Ma, Xiao-Zhou Mou, Ya-Hui Ding, Hai Zou & Dong-Sheng Huang. (2016) Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents. Expert Opinion on Drug Delivery 13:10, pages 1397-1406.
Read now
Rebecca J. Watters, Todd E. Fox, Su-Fern Tan, Sriram Shanmugavelandy, Jacob E. Choby, Kathleen Broeg, Jason Liao, Mark Kester, Myles C. Cabot, Thomas P. Loughran & Xin Liu. (2013) Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia. Leukemia & Lymphoma 54:6, pages 1288-1296.
Read now
Clara De Palma & Cristiana Perrotta. (2012) Ceramide as a target of chemotherapy: its role in apoptosis and autophagy. Clinical Lipidology 7:1, pages 111-119.
Read now

Articles from other publishers (51)

E. Andrew Thim, Todd Fox, Tye Deering, Luke R. Vass, Natasha D. Sheybani, Mark Kester & Richard J. Price. (2023) Solid tumor treatment via augmentation of bioactive C6 ceramide levels with thermally ablative focused ultrasound. Drug Delivery and Translational Research 13:12, pages 3145-3153.
Crossref
Han Zhu, Hua-Jie Chen, Hai-Yan Wen, Zhi-Gang Wang & Shu-Lin Liu. (2023) Engineered Lipidic Nanomaterials Inspired by Sphingomyelin Metabolism for Cancer Therapy. Molecules 28:14, pages 5366.
Crossref
Yasharah Raza, Jane Atallah & Chiara Luberto. (2022) Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies. International Journal of Molecular Sciences 23:21, pages 12745.
Crossref
Osmel Companioni, Cristina Mir, Yoelsis Garcia-Mayea & Matilde E. LLeonart. (2021) Targeting Sphingolipids for Cancer Therapy. Frontiers in Oncology 11.
Crossref
Sunil C. Gurumallu & Rajesha Javaraiah. (2021) Bioactives in Disease Prevention and Health Promotion: Exploiting Combinatorial Effects. Current Bioactive Compounds 17:4, pages 299-317.
Crossref
Ana F. Cruz, Mariana B. Caleiras, Nuno A. Fonseca, Nélio Gonçalves, Vera M. Mendes, Susana F. Sampaio, Vera Moura, Joana B. Melo, Ramiro D. Almeida, Bruno Manadas, Sérgio Simões & João N. Moreira. (2021) The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway. Cancers 13:12, pages 3052.
Crossref
Feng Gao, Xiaoxu Chen, Junyan Lu, Shulei Hu, Hui Xu, Yuqiang Shi, Mingshun Feng, Jian Ding, Hong Liu, Cheng Luo, Zuoquan Xie & Jiang Wang. (2021) Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer. European Journal of Medicinal Chemistry 215, pages 113274.
Crossref
Kai-Fu Chang, Xiao-Fan Huang, Yu-Ling Lin, Kuang-Wen Liao, Ming-Chang Hsieh, Jinghua Tsai Chang & Nu-Man Tsai. (2021) Positively Charged Nanoparticle Delivery of n-Butylidenephthalide Enhances Antitumor Effect in Hepatocellular Carcinoma. BioMed Research International 2021, pages 1-14.
Crossref
Yoshiaki Yura, Atsushi Masui & Masakazu Hamada. (2020) Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma. Cancers 12:8, pages 2062.
Crossref
Kai-Fu Chang, Jinghua Tsai Chang, Xiao-Fan Huang, Yu-Ling Lin, Kuang-Wen Liao, Chien-Wei Huang & Nu-Man Tsai. (2020) Antitumor Effects of N-Butylidenephthalide Encapsulated in Lipopolyplexs in Colorectal Cancer Cells. Molecules 25:10, pages 2394.
Crossref
Min-Koo Choi & Im-Sook Song. (2020) Recent advances in the formulation of sphingolipid anticancer therapeutics. Journal of Pharmaceutical Investigation 50:3, pages 295-307.
Crossref
Jianzhong Chen, Sachin K Khiste, Xiaomei Fu, Kartik R. Roy, Yixuan Dong, Jian Zhang, Mei Liu, Yong-Yu Liu & Zhijun Liu. (2020) Rubusoside-assisted solubilization of poorly soluble C6-Ceramide for a pilot pharmacokinetic study. Prostaglandins & Other Lipid Mediators 146, pages 106402.
Crossref
Anna Kovilakath & L. Ashley Cowart. (2020) Sphingolipid Mediators of Myocardial Pathology. Journal of Lipid and Atherosclerosis 9:1, pages 23.
Crossref
Chang Moo Kang, BoKyeong Yun, Minju Kim, Mina Song, Yeon-hee Kim, Sung Hwan Lee, Hosun Lee, Song Mi Lee & Seung-Min Lee. (2019) Postoperative serum metabolites of patients on a low carbohydrate ketogenic diet after pancreatectomy for pancreatobiliary cancer: a nontargeted metabolomics pilot study. Scientific Reports 9:1.
Crossref
Hamad Alrbyawi, Ishwor Poudel, Ranjeet Prasad Dash, Nuggehally R. Srinivas, Amit K Tiwari, Robert D. Arnold & R. Jayachandra Babu. (2019) Role of Ceramides in Drug Delivery. AAPS PharmSciTech 20:7.
Crossref
Ruofan Cao, Horst Wallrabe, Chunbo Huang, Su-Fern Tan, David Feith, Yuan Xing, Yong Wang, Jose Oberholzer, Mark Kester, Thomas P. Loughran & Ammasi Periasamy. (2019) FLIM Imaging of NAD(P)H to track metabolic changes of non-adherent leukemia cells using micro cell trapping arrays. FLIM Imaging of NAD(P)H to track metabolic changes of non-adherent leukemia cells using micro cell trapping arrays.
Ruofan Cao, Horst K. Wallrabe, Chunbo Huang, Su-Fern Tan, David Feith, David Feith, Yuan Xing, Yong Wang, Jose Oberholzer, Mark Kester, Thomas Loughran & Ammasi Periasamy. (2019) FLIM imaging of auto-fluorescent NAD(P)H and FAD to track metabolic changes of non-adherent leukemia cells using microfluidic trapping array. FLIM imaging of auto-fluorescent NAD(P)H and FAD to track metabolic changes of non-adherent leukemia cells using microfluidic trapping array.
Megan L. Sulciner, Allison Gartung, Molly M. Gilligan, Charles N. Serhan & Dipak Panigrahy. (2018) Targeting lipid mediators in cancer biology. Cancer and Metastasis Reviews 37:2-3, pages 557-572.
Crossref
Magali Trayssac, Yusuf A. Hannun & Lina M. Obeid. (2018) Role of sphingolipids in senescence: implication in aging and age-related diseases. Journal of Clinical Investigation 128:7, pages 2702-2712.
Crossref
Guangfu Li, Dai Liu, Eric T. Kimchi, Jussuf T. Kaifi, Xiaoqiang Qi, Yariswamy Manjunath, Xinjian Liu, Tye Deering, Diego M. Avella, Todd Fox, Don C. Rockey, Todd D. Schell, Mark Kester & Kevin F. Staveley-O’Carroll. (2018) Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice. Gastroenterology 154:4, pages 1024-1036.e9.
Crossref
Xuewei Zhang, Kazuyuki Kitatani, Masafumi Toyoshima, Masumi Ishibashi, Toshinori Usui, Junko Minato, Mahy Egiz, Shogo Shigeta, Todd Fox, Tye Deering, Mark Kester & Nobuo Yaegashi. (2018) Ceramide Nanoliposomes as a MLKL-Dependent, Necroptosis-Inducing, Chemotherapeutic Reagent in Ovarian Cancer. Molecular Cancer Therapeutics 17:1, pages 50-59.
Crossref
Ahmed Elsherbini & Erhard Bieberich. 2018. Sphingolipids in Cancer. Sphingolipids in Cancer 121 154 .
Jeremy Shaw, Pedro Costa-Pinheiro, Logan Patterson, Kelly Drews, Sarah Spiegel & Mark Kester. 2018. Sphingolipids in Cancer. Sphingolipids in Cancer 327 366 .
Tess V. Dupre, Mark A. Doll, Parag P. Shah, Cierra N. Sharp, Deanna Siow, Judit Megyesi, James Shayman, Alicja Bielawska, Jacek Bielawski, Levi J. Beverly, Maria Hernandez-Corbacho, Christopher J. Clarke, Ashley J. Snider, Rick G. Schnellmann, Lina M. Obeid, Yusuf A. Hannun & Leah J. Siskind. (2017) Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury. Journal of Lipid Research 58:7, pages 1439-1452.
Crossref
S.L. Craig & V.B. Jensen. 2017. Nanotechnology in Cancer. Nanotechnology in Cancer 45 69 .
Samy A.F. Morad, Terence E. Ryan, P. Darrell Neufer, Tonya N. Zeczycki, Traci S. Davis, Matthew R. MacDougall, Todd E. Fox, Su-Fern Tan, David J. Feith, Thomas P. LoughranJr.Jr., Mark Kester, David F. Claxton, Brian M. Barth, Tye G. Deering & Myles C. Cabot. (2016) Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia. Journal of Lipid Research 57:7, pages 1231-1242.
Crossref
Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim & Yusuf Baran. (2016) Major apoptotic mechanisms and genes involved in apoptosis. Tumor Biology 37:7, pages 8471-8486.
Crossref
Samuel S. Linton, Samantha G. Sherwood, Kelly C. Drews & Mark Kester. (2015) Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine. WIREs Nanomedicine and Nanobiotechnology 8:2, pages 208-222.
Crossref
Carolina Torres, Ana Linares, Maria Jose Alejandre, Rogelio Jesus Palomino-Morales, Juan Ramon Delgado & Sonia Perales. (2016) Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells. Pancreas 45:2, pages 269-280.
Crossref
Samy A.F. Morad & Myles C. Cabot. (2015) Tamoxifen regulation of sphingolipid metabolism—Therapeutic implications. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1851:9, pages 1134-1145.
Crossref
Samy A.F. Morad, Su-Fern Tan, David J. Feith, Mark Kester, David F. Claxton, Thomas P. LoughranJr.Jr., Brian M. Barth, Todd E. Fox & Myles C. Cabot. (2015) Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia—Impact on enzyme activity and response to cytotoxics. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1851:7, pages 919-928.
Crossref
Mark Kester, Jocelyn Bassler, Todd E. Fox, Carly J. Carter, Jeff A. Davidson & Mylisa R. Parette. (2015) Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic. Biological Chemistry 396:6-7, pages 737-747.
Crossref
Carla Hajj, Katrin Anne Becker-Flegler & Adriana Haimovitz-Friedman. (2015) Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways. Biological Chemistry 396:6-7, pages 669-679.
Crossref
Patricia Coutinho de Souza, Ashish Ranjan & Rheal A Towner. (2015) Nanoformulations for therapy of pancreatic and liver cancers. Nanomedicine 10:9, pages 1515-1534.
Crossref
Sehamuddin Galadari, Anees Rahman, Siraj Pallichankandy & Faisal Thayyullathil. (2015) Tumor suppressive functions of ceramide: evidence and mechanisms. Apoptosis 20:5, pages 689-711.
Crossref
Pu Zhang, Changliang Fu, Yijuan Hu, Cheng Dong, Yang Song & Erqun Song. (2015) C6-ceramide nanoliposome suppresses tumor metastasis by eliciting PI3K and PKCζ tumor-suppressive activities and regulating integrin affinity modulation. Scientific Reports 5:1.
Crossref
Jeremy K. Haakenson, Andrei V. Khokhlatchev, Younhee J. Choi, Samuel S. Linton, Pu Zhang, Peter M. Zaki, Changliang Fu, Timothy K. Cooper, Andrea Manni, Junjia Zhu, Todd E. Fox, Cheng Dong & Mark Kester. (2015) Lysosomal Degradation of CD44 Mediates Ceramide Nanoliposome-induced Anoikis and Diminished Extravasation in Metastatic Carcinoma Cells. Journal of Biological Chemistry 290:13, pages 8632-8643.
Crossref
Sabrina Di Bartolomeo, Antonio Agostini & Angelo Spinedi. (2015) Differential apoptotic effect and metabolism of N-acetylsphingosine and N-hexanoylsphingosine in CHP-100 human neurotumor cells. Biochemical and Biophysical Research Communications 458:3, pages 456-461.
Crossref
Nicole Sänger, Eugen Ruckhäberle, Balazs Györffy, Knut Engels, Tomas Heinrich, Tanja Fehm, Anna Graf, Uwe Holtrich, Sven Becker & Thomas Karn. (2015) Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer. Molecular Oncology 9:1, pages 58-67.
Crossref
Ushma A. Doshi, Jeremy K. Haakenson, Samuel S. Linton, Kimberly Kelly & Mark Kester. 2015. Bioactive Sphingolipids in Cancer Biology and Therapy. Bioactive Sphingolipids in Cancer Biology and Therapy 401 436 .
Samy A. F. Morad & Myles C. Cabot. 2015. Bioactive Sphingolipids in Cancer Biology and Therapy. Bioactive Sphingolipids in Cancer Biology and Therapy 211 233 .
Qian Wang, Jian Zou, Xiufen Zhang, Huijun Mu, Ying Yin & Ping Xie. (2014) Glucosylceramide synthase promotes Bcl-2 expression via the ERK signaling pathway in the K562/A02 leukemia drug-resistant cell line. International Journal of Hematology 100:6, pages 559-566.
Crossref
Mayur Yergeri, Sonali Kapse-Mistry, Rohit Srivastava & Thirumala Govender. (2014) Nanodrug delivery in reversing multidrug resistance in cancer cells. Frontiers in Pharmacology 5.
Crossref
L Bizzozero, D Cazzato, D Cervia, E Assi, F Simbari, F Pagni, C De Palma, A Monno, C Verdelli, P R Querini, V Russo, E Clementi & C Perrotta. (2013) Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway. Cell Death & Differentiation 21:4, pages 507-520.
Crossref
Rogério S. Gaspar, Helena F. Florindo, Liana C. Silva, Mafalda A. Videira, M. Luísa Corvo, Bárbara F. Martins & Beatriz Silva-Lima. 2014. Nano-Oncologicals. Nano-Oncologicals 425 452 .
Lindsay K. Ryland, Ushma A. Doshi, Sriram S. Shanmugavelandy, Todd E. Fox, Cesar Aliaga, Kathleen Broeg, Kendall Thomas Baab, Megan Young, Osman Khan, Jeremy K. Haakenson, Nancy Ruth Jarbadan, Jason Liao, Hong-Gang Wang, David J. Feith, Thomas P. Loughran Jr, Xin Liu & Mark Kester. (2013) C6-Ceramide Nanoliposomes Target the Warburg Effect in Chronic Lymphocytic Leukemia. PLoS ONE 8:12, pages e84648.
Crossref
Samy A. F. Morad & Myles C. Cabot. (2012) Ceramide-orchestrated signalling in cancer cells. Nature Reviews Cancer 13:1, pages 51-65.
Crossref
Daniel Canals & Yusuf A. Hannun. 2013. Sphingolipids: Basic Science and Drug Development. Sphingolipids: Basic Science and Drug Development 211 238 .
Jody L. Hankins, Ushma A. Doshi, Jeremy K. Haakenson, Megan M. Young, Brian M. Barth & Mark Kester. 2013. Sphingolipids: Basic Science and Drug Development. Sphingolipids: Basic Science and Drug Development 197 210 .
Samy A.F. Morad, Jonathan C. Levin, Sriram S. Shanmugavelandy, Mark Kester, Gemma Fabrias, Carmen Bedia & Myles C. Cabot. (2012) Ceramide–Antiestrogen Nanoliposomal Combinations—Novel Impact of Hormonal Therapy in Hormone-Insensitive Breast Cancer. Molecular Cancer Therapeutics 11:11, pages 2352-2361.
Crossref
Rebecca J. Watters, Mark Kester, Melissa A. Tran, Thomas P. LoughranJr.Jr. & Xin Liu. 2012. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases 89 108 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.